Search - tctmd.com

Displaying 1 - 19 of 19

Sort: Relevancy | Date

News Daily News

ACC Issues New Guidance Around Antithrombotic Choices in A-fib, VTE

Todd Neale

December 22, 2020

News Daily News

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Shelley Wood

December 17, 2020

News Opinion CV Team Dispatch

November 2020 News Roundup

L.A. McKeown

November 01, 2020

News Daily News

CMS Weighs Medicare Coverage at the Time of FDA Approval for Breakthrough Devices

Michael O'Riordan

October 30, 2020

News Opinion CV Team Dispatch

October 2020 News Roundup

L.A. McKeown

October 01, 2020

News Opinion CV Team Dispatch

September 2020 News Roundup

L.A. McKeown

September 01, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2020

Caitlin E. Cox

August 28, 2020

News Daily News

Cannabis Has No CV Benefits and Substantial Risks, Says AHA Statement

Yael L. Maxwell

August 06, 2020

News Features

COVID-19’s Enduring Impact on the Heart? Some Clues and Predictions

Shelley Wood

July 20, 2020

News Daily News

Heart, Kidneys, Brain, and More: COVID-19’s Wide-ranging Effects

Michael O'Riordan

July 13, 2020

News Conference News EuroPCR 2020

Cardiac Arrests Have Soared Worldwide: How Was COVID-19 to Blame?

Shelley Wood

June 29, 2020

News Daily News

US Prescriptions During COVID-19: Hydroxychloroquine Soars, CVD Drugs Stable

Shelley Wood

May 29, 2020

News Features

Dire, Unusual STEMI Complications Blamed on COVID-19 Hospital Avoidance

Shelley Wood

April 29, 2020

News Features

Hopes High for Anti-inflammatories to Combat COVID-19 Immune System Storms

Caitlin E. Cox

April 23, 2020

News Daily News

COVID-19 Drug Candidates May Raise Arrhythmia Risk

Caitlin E. Cox

April 03, 2020

News Conference News ACC 2020

Aspirin Okay for Up to 30 Days in A-fib Patients After ACS or PCI: AUGUSTUS

Todd Neale

April 03, 2020

News Daily News

More Support for DOAC-Based Double Therapy After PCI for A-fib Patients

Todd Neale

March 16, 2020

News Daily News

Antiplatelets Add Risk in Newly Diagnosed A-fib Patients: GARFIELD-AF

Caitlin E. Cox

March 02, 2020

News Daily News

New Meta-analysis Supports NOAC Plus P2Y12 Inhibitor for PCI in A-fib

Shelley Wood

February 28, 2020

Advertisement

ACC Issues New Guidance Around Antithrombotic Choices in A-fib, VTE

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

November 2020 News Roundup

CMS Weighs Medicare Coverage at the Time of FDA Approval for Breakthrough Devices

October 2020 News Roundup

September 2020 News Roundup

TCTMD’s Top 10 Most Popular Stories for August 2020

Cannabis Has No CV Benefits and Substantial Risks, Says AHA Statement

COVID-19’s Enduring Impact on the Heart? Some Clues and Predictions

Heart, Kidneys, Brain, and More: COVID-19’s Wide-ranging Effects

Cardiac Arrests Have Soared Worldwide: How Was COVID-19 to Blame?

US Prescriptions During COVID-19: Hydroxychloroquine Soars, CVD Drugs Stable

Dire, Unusual STEMI Complications Blamed on COVID-19 Hospital Avoidance

Hopes High for Anti-inflammatories to Combat COVID-19 Immune System Storms

COVID-19 Drug Candidates May Raise Arrhythmia Risk

Aspirin Okay for Up to 30 Days in A-fib Patients After ACS or PCI: AUGUSTUS

More Support for DOAC-Based Double Therapy After PCI for A-fib Patients

Antiplatelets Add Risk in Newly Diagnosed A-fib Patients: GARFIELD-AF

New Meta-analysis Supports NOAC Plus P2Y12 Inhibitor for PCI in A-fib

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content